TOPRA is committed to continuing to support the education of regulatory professionals in this unprecedented situation. However, in light of recent developments and the advice from health authorities, we have made the decision for this course to go ahead as an interactive online course on the same date with many opportunities for questions to the speakers. All delegates already booked on the course will be individually contacted and if you require further information please email meetings@topra.org.
When: 6-10 July 2020
Time: Approximately 12:00–17:00 BST (GMT+1) daily (see course programme for specific times for each day)
Where: Online
Course overview
With a growing trend in the crossover between pharmaceutical and medical device regulatory affairs, it is becoming increasingly important for pharmaceutical regulatory professionals to be aware of the issues surrounding medical device regulatory affairs.
Put together by practicing medical device regulatory affairs professionals, this newly researched and updated course is demanded by regulatory affairs managers who wish to get their people up to speed on current European medical device regulatory practices.
You will return to your office a more confident and proactive medical device regulatory affairs professional who will be able to determine which directives apply to which products, classify medical devices, assess borderlines issues and establish and maintain an internal audit programme and a supplier audit programme.
The course will also enable you to prepare and manage a third party audit, recognise diverse country requirements, advise on how to conduct a clinical investigation and implement a copy approval process.
Benefits to delegates
Delegates will learn:
- The role of the essential requirements / harmonised standards and how to demonstrate conformity.
- The different conformity assessment routes and how to select the most appropriate route for their product
- The role of risk management in pre and post market phase and be able to advise on a risk management policy and procedure.
- The need for clinical evidence for CE marking
- The needs of payers and how to include these as part of the development of the device regulatory package.
- The key elements within a PMS system
- The criteria for vigilance and the Competent Authority (CA) expectations
- The minimum requirements and CA expectations for implementing an FSCA.
- The impact of marketing literature on regulatory status
- The unique requirements of the IVD Directive
CPD: This course provides 23 CPD hours upon successful completion
To learn more about why Continuing Professional Development is important, visit our Lifelong Learning page.
Programme
You can download the current programme here.
Presenters
Suitable for
- Those with 1-2 years experience in Medical Devices
- Those who want a broader understanding of Medical Devices
- Anyone who works in other areas of Regulatory Affairs who is looking to move into, has an interest in or would like further understanding of Medical Devices
- Anyone in medicines regulation who works with Drug Device Combination Products
Pricing
| Type |
Member or TOPRA MSc Student |
Non-member |
| Standard |
£1,500+VAT |
£1,700+VAT |
Discounted places
A limited number of discounted places are available at the rates below.
Please email us at meetings@topra.org for a discount code before making your booking.
Please note that discounted places are not valid for those enrolled on the MSc course and cannot be used in conjunction with any other offer.
|
|
Those working for regulatory agencies, government agencies or academic institutions
|
£1,125+VAT
|
£1,275+VAT |
Those working for charities, patient groups or are in full-time education
|
Please contact the TOPRA office
meetings@topra.org |
Please contact the TOPRA office
meetings@topra.org |
*VAT, if applicable, is charged at VAT rate of 20%
Howard Dobbs